Bellevue Life Sciences-WRNTOSRHWPreferred / convertible

13F holders, Q2 2026 (June 30)
19holders +3
5new positions
2sold out
1famous investor
$0.06avg. 13F price*

At the end of Q2 2026, 19 institutions reported holding Bellevue Life Sciences-WRNT (OSRHW) in their 13F filings, up 3 from Q1 2026. 5 opened new positions and 2 sold out. The largest holders were Toronto Dominion Bank ($32K), Boothbay Fund Management, LLC ($30K) and Polar Asset Management Partners Inc. ($19K). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).

Company
Bellevue Life Sciences-WRNT
Filed as
OSR HEALTH INC (Q2 2026)
CUSIP
68840D110
Latest filing quarter
Q2 2026

History

Number of 13F holders

0510152025 Q1 2025: 20Q1 2025Q2 2025: 21Q2 2025Q3 2025: 20Q3 2025Q4 2025: 17Q4 2025Q1 2026: 16Q1 2026Q2 2026: 19Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions5$5K
Exits2$3K

All 13F filers, Q1 2026 → Q2 2026: 90,285 shares bought and 55,892 shares sold, net +34,393 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 19 holders

Toronto Dominion Bank — Reduce -1.3% 604,164 $32K
Boothbay Fund Management, LLC — No change 95,040 $30K
Polar Asset Management Partners Inc. — No change 360,000 $19K
Periscope Capital Inc. — No change 299,900 $16K
Clear Street Group Inc. — Reduce -0.1% 291,824 $15K
LMR Partners LLP — No change 253,001 $13K
Saba Capital Management, L.P. — No change 250,000 $13K
D. E. Shaw & Co. — No change 150,000 $8K
Rivernorth Capital Management, LLC — No change 250,000 $8K
Wolverine Asset Management LLC — No change 111,585 $6K
Centiva Capital, LP — No change 100,000 $5K
Mint Tower Capital Management B.V. — No change 75,000 $4K
Aristeia Capital, L.L.C. — No change 73,341 $4K
SkyView Investment Advisors, LLC — New 30,000 $2K
Susquehanna International Group, LLP — New 21,458 $1K
Flow Traders U.S. LLC — Add +1.9% 24,173 $1K
HRT Financial LP — New 19,146 $1K
Two Sigma Securities, LLC — New 17,891 $948
UBS Group AG — New 1,347 $71

"% of holder's portfolio" is OSRHW's weight in each manager's 13F, not the share of Bellevue Life Sciences-WRNT the manager owns.